Trial Profile
An Open-label Pilot Study Evaluating the Effect of a Combination Regimen of Herceptin, Cisplatin, and Gemcitabine on Time to Disease Progression in Patients With Metastatic Urothelial Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary) ; Cisplatin; Gemcitabine
- Indications Urogenital cancer
- Focus Therapeutic Use
- Sponsors Roche
- 16 Dec 2013 New source identified and integrated, ClinicalTrials.gov record.
- 23 Feb 2010 Status changed from recruiting to completed as reported by Roche Record.
- 23 Jul 2009 Status changed from active, no longer recruiting to recruiting as reported by Roche record.